Cargando…
The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives
The pathogenesis, clinical course, and response to treatment in systemic juvenile idiopathic arthritis (SJIA) differ from other types of juvenile idiopathic arthritis and are similar to other interleukin-1 (IL-1)-mediated diseases. The main cytokine involved in the pathogenesis of SJIA is IL-1β, whi...
Autores principales: | Toplak, Nataša, Blazina, Štefan, Avčin, Tadej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996857/ https://www.ncbi.nlm.nih.gov/pubmed/29922038 http://dx.doi.org/10.2147/DDDT.S114532 |
Ejemplares similares
-
Clinical and MRI outcome of cervical spine lesions in children with juvenile idiopathic arthritis treated with anti-TNFα drugs early in disease course
por: Ključevšek, Damjana, et al.
Publicado: (2017) -
Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
por: Avramovič, Mojca Zajc, et al.
Publicado: (2014) -
The Slovene version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Toplak, Natasa, et al.
Publicado: (2018) -
PReS-FINAL-2314: Anti-TNF alpha therapy for refractory childhood takayasu arthritis
por: Koren, B, et al.
Publicado: (2013) -
PReS-FINAL-2084: Prevalence of cervical spine involvement in children with juvenile idiopathic arthritis
por: Semolič, N, et al.
Publicado: (2013)